Searched for
GLENN SALDANHA CMD GLENMARK PHARMA
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- IAIRO appoints AvenuesAI's CMD Vishal Mehta as Technical AdvisorThe Indian AI Research Organisation (IAIRO), a fast-rising institution at the centre of India's sovereign artificial intelligence ambitions...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit MishraIndian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative streng...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Indian pharma may take AI pill to cut time and costs in drug R&DIndian pharmaceutical giants Sun Pharma and Glenmark are embracing Artificial Intelligence to speed up new drug creation. This technology p...
- Glenmark Pharma draws up capex of USD 300 mn over next 3 yearsGlenmark along with its subsidiaries operate 17 manufacturing facilities across four countries and has five research and development center...
- Temasek Holdings to buy 3.83 % in Glenmark Pharma for Rs 945 crTemasek Holdings will buy a 3.83% stake in Glenmark Pharma for Rs 945 cr in one of the largest private equity deals in a listed Indian phar...
- Expect 12-15% growth from US market in FY15: Glenn SaldanhaWe did not get any new approval in Q1 and last year also we struggled a little bit in terms of getting product approvals, says Glenn Saldan...
- Slowdown grips domestic pharma market, records sluggish growth for OctoberThe domestic pharma industry is now witnessing a big slowdown with October becoming the third consecutive month to record sluggish growth.
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.
- Napo termination will not impact company: GlenmarkIn an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...
- Glenmark to enter Europe with Rs 100 crore buyLeading mid-sized pharma company Glenmark Pharmaceuticals would soon enter the European market by acquiring a front-end pharmaceutical comp...
- Drug research was way forward: GlenmarkAfter much analysis, consultants advised Glenmark Pharmaceuticals to stay away from research as it lacked the resources needed for innovati...
- Glenmark, Sun to sell generic version of Trileptal in USGlenmark Pharmaceuticals and Sun Pharmaceutical Industries separately announced that they received approval to sell generic versions of Nov...
- Glenmark, Dyax sign research pactGlenmark Pharmaceuticals has entered into a collaborative research agreement with US biopharmaceutical company Dyax for the development of ...
- Dyax Corp, Glenmark ink research agreementGlenmark Pharmaceuticals SA and Dyax Corp has said they have entered into a funded research agreement for the discovery of therapeutic anti...
- Glenmark to make Europe foray with Rs 100 cr buyLeading mid-sized pharma company Glenmark Pharmaceuticals will soon enter the European market by acquiring a front-end pharmaceutical compa...
Load More
